? Call for Submissions – Middle Eastern Cancer and Oncology Journal (MECOJ)
We are pleased to announce that the Middle Eastern Cancer and Oncology Journal (MECOJ) has officially obtained its ISSN number,
At OncoEval Pioneers Group, we are dedicated to advancing the field of oncology through innovation and leadership. Our vision is to revolutionize the field of oncology by developing innovative assessment tools and conducting transformative research. Our mission is to develop cutting-edge assessment tools, conduct groundbreaking research, and support the next generation of scholars and practitioners
Its an approach that brings together the best Medical planning and consultancy
Discover our latest contributions to the field of oncology. This section showcases our published research, key findings, and highlights from ongoing projects. Stay up to date with our work as we continue to push the boundaries of knowledge and explore new methodologies to enhance cancer treatment and care.
Stay informed about upcoming events, workshops, and webinars hosted by OncoEval Pioneers Group. We offer opportunities for oncology professionals to engage with experts, learn about the latest innovations, and discuss challenges in the field.
At the OncoEval Pioneers Group, we are not just committed to advancing the field of oncology; we are driven by a deep passion to make a tangible difference in the lives of patients, clinicians, and researchers alike. Whether through the creation of groundbreaking tools, the pursuit of cutting-edge research, or the mentorship of future leaders, our work is rooted in a desire to lead transformative change. We invite you to join us in our mission. Whether you are a researcher looking to collaborate, a clinician in need of innovative assessment tools, or an aspiring scholar seeking mentorship, we welcome you to be part of a community that is shaping the future of oncology. Together, we can drive advancements that will define the next era of cancer care.
Collaboration is at the heart of innovation. At OncoEval Pioneers Group, we work closely with leading academic institutions, hospitals, and industry partners to drive meaningful progress in oncology. This section highlights our key partnerships and the collaborative projects that are helping to shape the future of cancer treatment and research.
We are pleased to announce that the Middle Eastern Cancer and Oncology Journal (MECOJ) has officially obtained its ISSN number,
In the ever-evolving world of cancer research, one of the most intriguing and promising frontiers is the use of bacteria—yes,
What is Biological Ageing? Biological ageing refers to the gradual accumulation of damage to biological systems over a lifetime. This
Cancer continues to be one of the leading causes of death worldwide, with millions of new cases diagnosed each year.
Thrombocytopenia, a condition marked by a low platelet count, is a common yet often under-discussed complication in cancer patients. Platelets
Introduction: A New Approach to Cancer Support In the ever-evolving landscape of cancer treatment, healthcare professionals are constantly searching for